TimothySKristedjaMD

PubMed

• 3 citations
  Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial.
  Espen B Ellingsen, Steven O'Day, Artur Mezheyeuski, Agnieszka Gromadka, Trevor Clancy, Timothy S Kristedja, Mohammed Milhem, Yousef Zakharia> ;Clinical Cancer Research. 2023 Aug 15
• 2 citations
  Phase I study of fixed dose gemcitabine plus epirubicin in patients with advanced solid malignancies.
  Daruka Mahadevan, Luke Dreisbach, Timothy Kristedja, Debbie Williams, Yrma Obregon, Sandy Kurtin, Daniel D. Von Hoff> ;American Journal of Clinical Oncology. 2009 Dec 1
• Immune gene polymorphisms predict overall survival for stage IV melanoma patients treated with biochemotherapy.
  Liu D, O'Day SJ, Yang D, Boasberg P, Milford R, Kristedja T, Groshen S, Weber JS> ;J. Clin. Oncol.. 2004-07-15
• 52 citations
  Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to ind...
  O'Day, S. J., Boasberg, P. D., Piro, L., Kristedja, T. S., Wang, H. J., Martin, M., Deck, R., Ames, P., Shinn, K., Kim, H., Fournier, P., Gammon, G.> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2002 Sep 17
• High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma.
  O'Day SJ, Boasberg PD, Kristedja TS, Martin M, Wang HJ, Fournier P, Cabot M, DeGregorio MW, Gammon G> ;Cancer. 2001-08-01
• Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melan...
  O'Day SJ, Gammon G, Boasberg PD, Martin MA, Kristedja TS, Guo M, Stern S, Edwards S, Fournier P, Weisberg M, Cannon M, Fawzy NW, Johnson TD, Essner R, Foshag LJ, Morto...> ;J. Clin. Oncol.. 1999-09-01
• Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study.
  Liu, D., O'Day, S. J., Yang, D., Boasberg, P., Milford, R., Kristedja, T., Groshen, S., Weber, J.> ;Clin Cancer Res. 2005 Feb 1
• Biochemotherapy for metastatic melanoma with limited central nervous system involvement.
  Boasberg, P. D., O'Day, S. J., Kristedja, T. S., Martin, M., Wang, H., Deck, R., Shinn, K., Ames, P., Tamar, B., Petrovich, Z.> ;Oncology. 2003
• Targeted agents in ovarian cancer.
  Kristedja, T. S., Morgan, R. J., Cristea, M.> ;Womens Health (Lond Engl). 2010 Sep
• Join now to see all